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Abstract  
Oxygen interacts with cells and can form highly reactive compounds in vivo known as reactive oxygen species 
(ROS). High levels of ROS can lead to cellular damage, oxidative stress, heart diseases and cancer. Known 
substances that are capable of halting the physiological process of oxidation in tissue are called antioxidants. 
This review covers developments in the field of antioxidant chemistry including interactions between 
antioxidants and ROS, topics about sources and natural occurrences, classification of antioxidants and a 
discussion of possible mechanisms. We also summarize examples of oxidative stress biomarkers. 
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Introduction to Interactions between Antioxidants and Reactive Oxygen Species 
The human body has developed an efficient antioxidant protection system. The body relies on several endogenous defense 
mechanisms to help protect against free radical induced cell damage. The term antioxidant refers to species that prevent oxidation 
reactions. The antioxidants are substances that, when present at low concentrations, significantly delay or inhibit oxidation [1]. 
The possible mechanisms of antioxidant action are often discussed based upon solubility. Antioxidants are hydrophilic (water 
soluble) or hydrophobic (soluble in lipids). In general, hydrophilic antioxidants react with oxidants in the cell cytosol and the 
blood plasma, while hydrophobic antioxidants protect cell membranes from lipid peroxidation. Both antioxidant groups, 
hydrophilic and hydrophobic, are substances that may protect cells from the damage caused by molecules known as reactive 
oxygen species (ROS). ROS are molecules with an incomplete electron shell and are more chemically reactive than those with 
complete electron shells. In the first step, the ROS releases an electron, and in the second step a new radical is formed. The 
reaction continues until ROS termination occurs when either the radical is stabilized or it simply decays into a new product. 
Incomplete electron shells of ROS make them more chemically reactive than those with complete electron shells. In biological 
systems, ROS are continuously being produced intracellularly by oxidation-reduction (redox) reactions [2,3]. ROS generated by 
electron-transfer reactions are superoxide anion radical (O2-.), hydrogen peroxide (H2O2), hydroxyl radicals (HO.), lipid alkoxyl 
(ROO.) and peroxyl radicals (HOO.). In other ways, ROS are generated by energy-transfer reactions such as singlet oxygen (1O2) 
and triplet carbonyl compounds. At lower concentrations ROS play a role in mutagenic activity and in response to pathogen 
attack. However, if ROS are present in higher concentrations it gives rise to oxidative stress [4].Briefly, the antioxidants are called 
a chain breaking compound. Insufficient levels of antioxidants, or inhibition of the antioxidant enzymes cause oxidative stress 
and may damage or kill cells. The term oxidative stress represents a shift towards the ROS amount in the ROS - antioxidant 
equilibrium balance that occurs in metabolism. There are multiple sources of ROS generation in vivo and thus ROS are classified 
into two groups (group 1) mitochondrial and (group 2) non-mitochondrial in origin. The mitochondrial ROS are generated in a 
non-enzymatic process respiratory chain [5]. Hyperglycemia induced generation of free radicals at the mitochondrial level is 
thought to be the major driver of the vicious cycle of oxidative stress in diabetes [6]. Briefly, intracellular glucose leads to an 
abundance of electron donors generated during the Kreb's cycle driving the inner mitochondrial membrane potential upward into 
a state that is associated with mitochondrial dysfunction and increased ROS production [7,8].  
Oxidative damage to deoxyribonucleic acid (DNA), proteins, and other macromolecules has been implicated in the 
pathogenesis of a wide variety of diseases, most notably heart disease and cancer [9]. When an oxygen molecule (O2) becomes 
electrically charged it removes electrons from other molecules, causing damage to the DNA and other molecules. Over time, 
such damage may become irreversible and lead to disease including cancer [10]. ROS can also mediate an indirect attack to 
DNA, primarily by reacting with other cellular components (i.e., phospholipids), resulting in the generation of secondary reactive 
intermediates that irreversibly couple to DNA bases, forming DNA adducts. Formation of DNA adducts is central in the 
carcinogenic process.  Antioxidants have therefore been considered as a means to modify and minimize the toxic effect of free 
radicals. When a cell with a damaged DNA strand divides, a mutation can arise which turn in carcinogenesis. Antioxidants 
decrease oxidative damage to DNA and diminish abnormal cell division [11,12]. 
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Figure 1 Reactive Oxygen Species Cause Damage to DNA which may Result in the Formation of Cancer Cells. 
Oxidation products of DNA bases (i.e., 5-hydroxyuracil,hydroxyguanine and thymine glycol) [13]have beenused as 
oxidative stress biomarkers. Also oxidation products of lipids (i.e., oxidized lipids, oxysterols and conjugated dienes) [14] 
and proteins (i.e., nitroamino acids, albumin dimer and crosslinked protein) [15] are recognized as oxidative stress 
biomarkers.  
Sources and Classification of Antioxidants and Reactive Oxygen Species 
Antioxidants represent types of endogenous and exogenous compounds that neutralize free radicals [16]. The enzymatic 
antioxidants include superoxide dismutase (SOD), glutathione peroxidase and catalase. Vitamin A, C, E, carotenoids, thiol 
antioxidant (e.g. thioredoxin, lipoic acid, glutathione) and flavonoids are non-enzymatic antioxidants. Vitamin C, vitamin E and 
carotenoids are among the most widely studied dietary antioxidants [17]. Vitamin C is considered the most important water-soluble 
antioxidant in extracellular fluids and helps to maintain the collagen production, and also helps with healing of wounds. It is a water 
soluble compound found mostly in oranges, red peppers, kiwifruit and grapefruits. Vitamin C can be found in high abundance in 
many fruits and vegetables and is also found in cereals, beef, poultry, and fish. Vitamin E was the first vitamin where scientists 
recognized the antioxidant effect which works in the cell membranes. Vitamin E is found in almonds, safflower, soybean oils, 
corn, and is also found in nuts, mangos and broccoli. β-carotene is found in sweet potatoes, carrots, squash, apricots, 
pumpkin, mangos and some green, leafy vegetables, including collard greens, spinach, and kale. Another antioxidant, 
vitamin A is found in three main forms: retinol (vitamin A1), 3,4-didehydroretinol (vitamin A2), and 3-hydroxy-retinol 
(vitamin A3). Foods rich in vitamin A include liver, sweet potatoes, carrots, milk, egg yolks, and cheese. Lutein is 
abundant in green, leafy vegetables such as collard greens, spinach, and kale. Lycopene is a potent antioxidant found 
 Bartusik D. American journals of Cancer Review 2014, 2:29-39  
  
Ivy Union Publishing | http: //www.ivyunion.org November 1 2014 | Volume 2 | Issue 1  
Page 4 of 11 
in tomatoes, watermelon, guava, papaya, apricots, pink grapefruit and red blood oranges.  
An inorganic exogenous antioxidant, selenium, is found in plant foods like rice and wheat. The amount of selenium 
in soil, which varies by region, determines the amount of selenium in the foods grown in that soil. It is capable of 
neutralizing ROS in the aqueous phase before lipid peroxidation is initiated. Sulfur containing phytochemicals, such 
as the allyl sulfides are found in the allium family of garlic, onions, and leeks. Isothyocyanates and sulphoraphane are 
in cabbage, broccoli, and cauliflower and have been shown to inhibit various steps in tumor development [18]. Indole 
antioxidants are also found in cruciferous vegetables, terpenes and in citrus oils [18]. Endogenous antioxidants are 
present in a wide range of concentrations in body fluids and tissues, with some such as glutathione or ubiquinone mostly present 
within cells, while others such as uric acid are more evenly distributed. Antioxidants presented in Table 1 include nutrient-derived 
antioxidants, antioxidant enzymes, and metal binding proteins. Numerous other antioxidant phytonutrients are present in a 
wide variety of plant foods. 
 
Table 1 Classifications of Endogenous and Exogenous Antioxidants and their Representative Compounds. 
Class of Antioxidants Representative Antioxidants 
 
Endogenous antioxidants [19] 
bilirubin 
thiols, lipoic acid, N-acetyl cysteine  
NADPH and NADH  
ubiquinone (coenzyme Q10)  
uric acid 
 
Enzymes [20] 
superoxide dismutase (SOD)  
iron-dependent catalase 
glutathione peroxidase 
 
Metal binding proteins with interacted metal [21,22] 
albumin  with  copper  
ceruloplasmin with copper  
metallothionein  with copper  
ferritin with iron 
myoglobin with iron 
transferrin with iron 
 
Exogenous dietary antioxidants [20] 
vitamin C  
vitamin E  
carotenoids and oxycarotenoids 
polyphenols 
 
In addition, metal binding proteins, such as ferritin, lactoferrin, albumin, and ceruloplasmin sequester free iron and copper ions 
that are capable of catalyzing oxidative reactions. Another group is synthetic antioxidants such as butylatedhydroxytoluene 
(BHT), butylatedhydroxyanisole (BHA) and propylgallate which are added to packaged and prepared foods to 
prevent oxidation and spoilage [23].   
ROS are capable of reacting with membrane lipids, nucleic acids, proteins and enzymes, and other small molecules, 
resulting in cellular damage. The main pathways to generate ROS are a consequence of aerobic metabolism, oxidative 
burst from phagocytes, and xenobiotic metabolism during general antioxidants actions. ROS and associated 
antioxidants [19-22] are presented in Table 2. 
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Table 2 Reactive Oxygen Species (ROS) and Corresponding Neutralizing Antioxidants 
 
Neutralizing Interacting Antioxidants Reactive Oxygen Species (ROS) 
vitamin C HO.andO2-. 
glutathione HO.andO2-. 
flavonoids HO., ROO.andO2-. 
lipoic acid HO. 
vitamin E ROO. 
beta carotene ROO. 
ubiquinone ROO. 
glutathione peroxidase ROO. 
superoxide dismutase (SOD) O2-. 
 
Under certain conditions, an excess of any one type of antioxidant in the absence of balance with the others may be 
counter-protective [24]. Superoxide dismutase (SOD) converts superoxide to hydrogen peroxide, while carotenoids 
scavenge singlet oxygen. Furthermore, there is now evidence that some antioxidants or ROS act as a cellular signaling to 
regulate the concentrations of antioxidants.  
In vivo Network of Antioxidants 
Antioxidants neutralize radicals preventing them from taking electrons from other molecules. When highly reactive 
oxidants breach specific intracellular defenses, the cells use antioxidant protection systems which are constituted by 
small antioxidant molecules, such as vitamin E and C, and carotenoids. Vitamin E is a lipid soluble vitamin, which 
concentrates mainly in the interior of membranes and blood proteins. It is the major lipid soluble antioxidant in 
human blood plasma. Vitamin E reacts at considerable rates with a variety of free radical species, with emphasis on 
lipid peroxyl radicals formed during lipid peroxidation. During the course of this reaction, as in any other 
antioxidant mechanisms, a free radical form of vitamin E is formed generated (Figure 2).  
 
 
 
 
 
Figure 2 Direct Reactions of Vitamin E with Hydroxyl Radical. 
The new radical species, the vitamin E radical, has a chemical reactivity lower than the original free radicals. 
Hence, the transfer of the radical character proceeds toward creating a less oxidizing species. Vitamin C, on the other 
hand, is a water-soluble vitamin that reacts with several radical species producing semidehydroascorbic acid or 
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ascorbyl radical (Figure 3).  
 
 
 
 
Figure 3 Direct Reactions of Vitamin C with Peroxyl Radical. 
Vitamin E and vitamin C act independently to destroy free radicals and also work together by reaction between the radical of 
vitamin E with vitamin C to produce vitamin E and ascorbyl radical (Figure 4). The interaction between vitamin E and Cis the 
synergistic antioxidant action [25,26]. 
 
 
 
Figure 4 Vitamin E Radical Reaction with Vitamin C. 
Vitamin E and coenzyme Q have a long side chain, which are indispensable for incorporation in membranes and 
lipoproteins. At the same time, the side chain reduces the mobility within and between the membranes and 
lipoproteins, reducing the apparent antioxidant capacity [27].The efficacy of scavenging radicals by antioxidants in 
the membranes and lipoprotein particles depends on the physical factors such as mobility of antioxidant and its 
chemical reactivity. Thus, the rate of scavenging peroxyl radicals by α-tocopherol in the membrane is smaller than 
that in homogeneous solution [28]. Cells contain two enzymes that can reduce the ascorbyl radical or 
semidehydroascorbate radical back to ascorbate: dehydroascorbatereductase and 
NADH-semidehydroascorbatereductase. Vitamin E is reacting mainly with peroxyl radicals formed during lipid 
peroxidation. The reactivity of vitamin E with lipid peroxyl radicals at the membrane yields the corresponding 
antioxidant-derived radical, vitamin E radical or tocopheroxyl radical. Vitamin C is a water-soluble vitamin and 
antioxidant that reacts with a variety of free radical species. The antioxidant-derived radical, ascorbyl radical, is 
recovered via dehydroascorbatereductase. Vitamin C is also present in the cytosol. The different 
compartmentalization of vitamins E and C provides a synergistic antioxidant mechanism by which the free radical 
character is transferred from the lipid phase (membrane) to the cytosol (Figure 5). 
 
 
 
 
 
 
 
Figure 5 In vivo Reaction of Vitamin E (tocopherol) and C (ascorbic acid) [25,26]. 
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Enzyme systems protect the cell against oxygen radical attack. Specific preventive antioxidants remove superoxide 
anion or hydrogen peroxide, the two required precursors of hydroxyl radical (HO.). The product of the superoxide 
dismutase-catalyzed reaction above is hydrogen peroxide (H2O2). Although the latter is less reactive than superoxide 
anion radical, it is still a strong oxidant and a precursor of hydroxyl radical (HO.) via a Fenton reaction. The cell 
possesses mechanisms by which hydrogen peroxide (H2O2) is readily reduced to water. The enzymes catalyzing this 
reaction are catalase and glutathione peroxide. Catalase is located in peroxisomes and glutathione peroxidase occurs 
in cytosol and in the mitochondrial matrix. It requires glutathione, a tripeptide present in high concentrations in most 
mammalian cells. 
Clinical Use of Antioxidants 
Clinical applications use only a few antioxidants including N-acetylcysteine (for acetaminophen toxicity), 
alfa-lipoic acid (for diabetic neuropathy) and some flavonoids (polyphenolic compounds present in dietary plants), 
such as micronized purified flavonoid fraction (diosmin and hesperidin) and oxerutins (for chronic venous 
insufficiency) as well as baicalein and catechins (for osteoarthritis) [29,30]. Increasing evidence suggests that 
gamma-tocopherol (the form of vitamin E) might be effective for preventingof colorectal cancer [31]. 
Epidemiological evidence consistently relates low antioxidant intake or low blood levels of antioxidants with 
increased cancer risk [32].  
Plasma concentrations of carotenoids (alpha- and β-carotene, canthaxanthin, beta-cryptoxanthin, lutein, lycopene, 
zeaxanthin) and vitamins A (retinol), C and E and dietary consumption of β-carotene and vitamins A, C, and E were 
determined in colon cancer. An association was observed between higher prediagnostic plasma retinol concentration 
and a lower risk of colon cancer. Additionally, inverse associations for dietary beta-carotene and dietary vitamins C 
and E with colon cancer were observed [33]. The plasma concentration of antioxidants are found for vitamin E (10 – 
40μM) [34],vitamin C (50 – 60μM) [35], vitamin A (1 – 3μM) [34], glutathione 4 μM [36],lipoic acid (0.1 – 0.7 μM) 
[37], uricacid  (200 – 400μM) [34]andcoenzyme Q (5 μM ) [38].  
Skin cells are constantly exposed to ROS and oxidative stress from exogenous and endogenous sources. The 
reduction of oxidative stress can be achieved by increasing levels of antioxidant defense in order to scavenge ROS 
[39]. Antioxidant therapy can be in the use of antioxidant enzyme and proenzymes, biogenic elements, drugs, 
synthetic antioxidants, and drugs with antioxidant activity [12]. The enzymatic antioxidant systems, such as copper, 
zinc, manganese superoxide dismutase, gluthatione peroxidase, gluthathionereductase, and catalase may remove the 
ROS directly or sequentially, preventing their excessive accumulation and consequent adverse effects. Non-enzymatic 
antioxidant systems consist of scavenging molecules that are endogenously produced such as glutathione, ubichinol, 
and uric acid or dietary such as vitamins C and E, carotenoids, lipoic acid and selenium [40]. To date, antioxidants are 
proven to be beneficial to protect healthy cells from anticancer therapy. In particular, amifostine is a radioprotectant 
drug that when dephosphorylated, protects normal but not malignant cells against oxygen-based radicals, alkylator or 
organoplatinum anticancer drugs.  Physical exercise results in an up-regulation of antioxidant defense mechanisms 
in various tissues, presumably due to increased levels of oxidative stress that occurs during exercise [41,42].Although 
easily available, antioxidants have a limitation. Possible explanation for the lack of benefit in clinical trials is that the 
trials have not lasted long enough. It may be impossible to show the benefits of antioxidant therapy over several years 
if the therapy is trying to reverse the results of several decades of oxidative stress. It is critical to remember that the 
lack of benefits seen in clinical trials to date does not disprove the central role of oxidative stress in atherosclerosis. 
Rather, these results challenge us to evaluate optimal antioxidant therapies [43].Well-established antioxidants derived 
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from the diet are vitamins C, E, A, and carotenoids, which have been studied intensively. In general, exogenous 
antioxidants can compensate for the lower plasma antioxidant levels often observed in pre-diabetic individuals, 
whether their diabetes is primarily genetic in origin or due to obesity and a sedentary lifestyle [44]. Vitamin E is the 
major lipid soluble antioxidant protecting lipids against peroxidative damage. Studies indicate that oxidative cleavage 
of the phytyl side chain is a major metabolic pathway in humans, operative at saturated vitamin E plasma 
concentrations [45]. Vitamin C and vitamin E have well-described antioxidant properties. Vitamin C has been shown 
to scavenge superoxide, hydrogen, peroxide, hydroxyl radical, peroxyl radicals efficiently. Ascorbic acid can also 
protect membranes against peroxidation by enhancing the activity of alpha-tocopherol, the chief lipid-soluble vitamin 
[46]. Although the value of vitamin C as a potential cancer treatment has been debated for decades, only one 
randomized clinical trial was found that evaluated vitamin C treatment concurrently with chemotherapy and reported 
on outcomes [46]. In 1994, over 100 studies have reported that reduction in cancer risk is associated with a diet high 
in vitamin C [47]. 
Coenzyme Q or ubiquinone may decrease oxidative stress not only by quenching reactive oxidant species but also 
by ‘recoupling’ mitochondrial oxidative phosphorylation, thereby reducing superoxide production. Alpha-lipoic acid, 
a critical co-factor for mitochondrial dehydrogenase reactions, is another compound with free radical-scavenging 
activity [48].Lipoic acid was found to increase glucose transport in cultured muscle cells by stimulating translocation 
of GLUT4 from internal pools to the plasma membrane. In cultured adipocytes, treatment with lipoic acid protected 
the insulin receptor from oxidative damage, maintaining its functional integrity. A placebo-controlled explorative 
study of patients with T2DM indicated that oral administration of lipoicacid significantly increased insulin-mediated 
glucose uptake, presumably by modulating insulin sensitivity[49].  
Carotenoids are natural compounds with lipophilic properties and β-carotene is the most prominent. Most 
carotenoids contain an extended system of conjugated double bonds, which is responsible for their antioxidant 
activity. The first large randomized trial on antioxidants and cancer risk was published in 1993. This trial 
investigated the effect of a combination of β-carotene, vitamin E, and selenium on cancer in healthy men and 
women at high risk for gastric cancer. The study showed a combination of β-carotene, vitamin E, and selenium 
significantly reduced incidence of both gastric cancer and cancer overall [50]. Another 1994 study, the 
Beta-Carotene and Retinol (vitamin A) Efficacy Trial (CARET), also demonstrated a possible increase in lung 
cancer associated with antioxidants [51]. The 1999 Women's Health Study (WHS) tested effects of vitamin E and 
beta-carotene in the prevention of cancer and cardiovascular disease among women age 45 years or older. Among 
apparently healthy women, there was no benefit or harm from beta-carotene supplementation. Investigation of the 
effect of vitamin E is ongoing [52-54]. A primary mechanism of many chemotherapy drugs against cancer cells is 
the formation of ROS, or free radicals. Drugs that form ROS include [55-57] melphalan, cyclophosphamide, 
anthracyclines (doxorubicin, epirubicin), podophyllin derivatives (etoposide), platinum coordination complexes 
(cisplatin, carboplatin), and camptothecins (topocan, irinotecan).  
Conclusion 
Oxygen interacts with cells in vivo and generates species such as hydroxyl radical, superoxide radical, hydrogen 
peroxide and singlet oxygen. All ROS are cytotoxic and have been implicated in the etiology of cancer. It is well 
documented that various stresses lead to the overproduction of ROS during oxidative stress process. Antioxidants 
act in vivo as a network that employs a series of redox reactions. A balanced combination of antioxidants may 
provide maximal efficacy in vivo due to their cooperative action, multiple interactions, location and reactivity. The 
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results presented in this review show antioxidants have potential for the lessening of toxic side effects caused by 
ROS and offer new strategies for further cancer research. 
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